Ann Arbor MI 转移性癌症临床试验
11项针对 转移性癌症的研究正在 Ann Arbor及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本(英文)
正在为研究招募参与者?将此页面置顶展示 — $99 / 30天 →
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
招募中2 期
- Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
- University of Michigan Rogel Cancer Center, Ann Arbor
- Huron Gastroenterology PC, Ypsilanti · 距离 7 英里
- 以及另外 6 项
A Study of ASP3082 in Adults With Advanced Solid Tumors
招募中1 期
- Trinity Health Ann Arbor Hospital, Ypsilanti · 距离 7 英里
ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer
招募中2 期
- University of Michigan Rogel Cancer Center, Ann Arbor
A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations
招募中1/2 期
- University of Michigan Medical School Rogel Cancer Center, Ann Arbor
A Clinical Study of Ifinatamab Deruxtecan Based Treatment Combinations or as Monotherapy to Treat Metastatic Castrate Resistant Prostate Cancer (mCRPC) (MK-2400-01A/IDeate-Prostate02)
招募中1/2 期
- University of Michigan ( Site 0021), Ann Arbor
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
招募中3 期
- University of Michigan, Ann Arbor
Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)
招募中3 期
- Research Site, Ann Arbor
- Research Site, Ann Arbor
Abiraterone, Enzalutamide, or Apalutamide in Castrate-sensitive Prostate Cancer.
招募中2 期
- VA Ann Arbor Healthcare System, Ann Arbor
A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
招募中1/2 期
- University of Michigan, Ann Arbor
Veterans Affairs Seamless Phase II/III Randomized Trial of STAndard Systemic theRapy With or Without PET-directed Local Therapy for Oligometastatic pRosTate Cancer
招募中2/3 期
- VA Ann Arbor Healthcare System, Ann Arbor, MI, Ann Arbor
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
招募中观察性研究
- Massive Bio SYNERGY-AI site, Ann Arbor
其他城市的 转移性癌症试验
- Houston, TX104 项研究
- New York City, NY93 项研究
- Nashville, TN70 项研究
- Boston, MA63 项研究
- Los Angeles, CA57 项研究
- St. Louis, MO54 项研究
- Arlington, VA53 项研究
- Philadelphia, PA46 项研究
- Chicago, IL45 项研究
- San Antonio, TX44 项研究
- Washington, DC43 项研究
- Dallas, TX42 项研究
Ann Arbor的其他研究
- 乳腺癌27 项研究
- 前列腺癌27 项研究
- 非小细胞肺癌26 项研究
- 癌症(所有类型)25 项研究
- 肺癌23 项研究
- 结直肠癌23 项研究
- 心力衰竭22 项研究
- 急性髓系白血病17 项研究
- 心血管疾病16 项研究
- 胰腺癌14 项研究
- 黑色素瘤12 项研究
- 卒中12 项研究
数据来自 ClinicalTrials.gov,检索日期:2026年10月6日。每项研究自行设定入选标准,由研究团队决定谁能参与。